Regioselective condensation of alkylidenephosphoranes to N-methoxy-and N-anilino-1 H isoindole-1,3-(2 H)-diones

Synthetic Communications

Volumn 42, Issue 13, 2012, Pages 1967-1978

  Abdou, Wafaa M ^a   Khidre, Rizk E ^a   Barghash, Reham F ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Alkylidenephosphoranes; inflammatory inhibition; N substituted phthalimides; olefination

Indexed keywords

1 (2 METHOXY 3 OXOISOINDOL 1 YL)PROPAN 2 ONE; 2 (2 METHOXY 3 OXOISOINDOL 1 YL) 1 PHENYLETHANONE; 2 (2 METHOXY 3 OXOISOINDOL 1 YL)ACETONITRILE; 2 (2 METHOXY 3 OXOISOINDOLIN 1 YLIDENE)ACETONITRILE; 2 METHOXY 3 (2 OXO 2 PHENYLETHYLIDENE)ISOINDOLIN 1 ONE; 2 METHOXY 3 (2 OXOPROYLIDENE)ISOINDOLIN 1 ONE; 2 METHOXYISOINDOLINE 1,3 DIONE; ALKENE; ALKYLIDENEPHOSPHORANE DERIVATIVE; ANTIINFLAMMATORY AGENT; ETHYL 2 (2 METHOXY 3 OXOISOINDOL 1 YL)ACETATE; ETHYL 2 (2 METHOXY 3 OXOISOINDOLIN 1 YLIDENE)ACETATE; ETHYL 2 [2 (PHENYLAMINO) 3 OXOISOINDOL 1 YL]ACETATE; ETHYL 2 [3 OXO 2 (PHENYLAMINO)ISOINDOLIN 1 YLIDENE]ACETATE; INDOMETACIN; METHYL 2 (2 METHOXY 3 OXOISOINDOL 1 YL)ACETATE; METHYL 2 (2 METHOXY 3 OXOISOINDOLIN 1 YLIDENE)ACETATE; METHYL 2 [2 (PHENYLAMINO) 3 OXOISOINDOL 1 YL]ACETATE; METHYL 2 [3 OXO 2 (PHENYLAMINO)ISOINDOLIN 1 YLIDENE]ACETATE; MONOALKENE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; IN VIVO STUDY; MALE; MICROWAVE RADIATION; NONHUMAN; PAW EDEMA; POLYMERIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STRUCTURE ACTIVITY RELATION;

EID: 84859206446     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397911.2010.551170     Document Type: Article

References (23)

1. Fahmy, A. F. Arkivoc. 2006, 7, 395-415.
2. Hargreaves, M. K.; Pritchard, J. G.; Dave, H. R. Chem. Rev. 1970, 70, 439-469.
3. Achinami, K.; Ashizawa, N.; Kobayashi, F. I 03,133,955, Chem. Abstr. 1991, 115, 255977.
4. Kato, Y.; Ebiik, H.; Achiwa, K.; Kurihara, T.; Kobayashi, F. Chem. Pharm. Bull. 1990, 38, 2060-2062.
5. Laboratori Baldacci DPA. Jpn. Patent JP 59 46, 268, 1984;
6. Chem. Abstr. 1984, 101, 54922.
7. Weiss, I.; Fidous, S.; Freyer, A. J.; Shamma, M.; Urzua, A.; Fayardo, V. Tetrahedron 1984, 40, 3957-4962.
8. Priestap, H. A. Phytochemistry 1985, 2444, 849-852.
9. Shaikhiev, I. G.; Fridland, S. V.; Mukhutdinova, G. M. Russ. J. Gen. Chem. 1999, 69, 557-559.
10. Abdou, W. M.; Ganoub, N. A.; Sabry, E. Z. Naturforschung 2009, 46b, 1057-1064.
11. Abdou, W. M.; Khidre, R. E. Montsh. Chem. 2010, 141, 219-228.
12. Silverstein, R. M.; Webster, F. X. W.; Kiemle, D. J. (eds). Spectrometric Identification of Organic Compounds; John Wiley and Sons: New York, 2005.
13. Couture, A.; Deniau, E.; Grandclaudon, P. Tetrahedron 1997, 53, 10313-10330.
14. Maryanoff, B. E.; Reitz, A. R. Chem. Rev. 1989, 89, 863-927.
15. Johnson, A. W. Ylides and Imines of Phosphorus; John Wiley & Sons: New York, 1993.
16. Gosney, I.; Rowley, A. G. In Organophosphorus Reagents in Organic Synthesis; Academic Press: London, 1979; chapter 2: pp. 17-153.
17. Bobbitt, J. M.; Katrizky, A. R.; Boulton A. L. (Eds.); Advances in Heterocyclic Chemistry 1973; Elsevier: New York, vol. 15, pp. 122-129.
18. (a) Sugasawa, S.; Matsuo, H. Chem. Pharm. Bull. Jp. 8, 819-826;
19. (b) Chem. Absr. 1961; 55, 20901.
20. http://www.ibmc.msk.ru/PASS
21. Poroikov, V. V.; Filimonov, D. A.; Ihlenfeld, W. D.; Gloriozova, T. A.; Lagunin, A. A.; Borodina, Y. V.; Stepanchikova, A. V.; Nicklaus, M. C. J. Chem. Inf. Comput. Sci. 2003, 43, 228-236.
22. Hadjipavlou-Litina, D. Res. Commun. Chem. Pathol. Pharmacol. 1993, 81, 1091-1102.
23. Kärber, C. Naunyn-Schmiedeberg's Arch. Pharmacol. 1931, 162, 480-487.